Works by Swedberg, Karl

Results: 289
    1

    Effects of sacubitril/valsartan according to background beta‐blocker therapy in patients with heart failure and reduced ejection fraction: Insights from PARADIGM‐HF.

    Published in:
    European Journal of Heart Failure, 2025, v. 27, n. 5, p. 779, doi. 10.1002/ejhf.3515
    By:
    • Gupta, Sharmistha Datta;
    • Butt, Jawad H.;
    • McMurray, Eoghan G.M.;
    • Talebi, Atefeh;
    • Matsumoto, Shingo;
    • Rizkala, Adel R.;
    • Henderson, Alasdair D.;
    • Desai, Akshay S.;
    • Lefkowitz, Martin;
    • Packer, Milton;
    • Rouleau, Jean L.;
    • Solomon, Scott D.;
    • Swedberg, Karl;
    • Zile, Michael R.;
    • Jhund, Pardeep S.;
    • McMurray, John J.V.
    Publication type:
    Article
    2
    3

    A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial.

    Published in:
    Heart Failure Reviews, 2012, v. 17, n. 3, p. 485, doi. 10.1007/s10741-011-9280-0
    By:
    • Gheorghiade, Mihai;
    • Pang, Peter;
    • Ambrosy, Andrew;
    • Lan, Gloria;
    • Schmidt, Philip;
    • Filippatos, Gerasimos;
    • Konstam, Marvin;
    • Swedberg, Karl;
    • Cook, Thomas;
    • Traver, Brian;
    • Maggioni, Aldo;
    • Burnett, John;
    • Grinfeld, Liliana;
    • Udelson, James;
    • Zannad, Faiez
    Publication type:
    Article
    4
    5
    6
    7
    8

    Sertraline Treatment of Major Depression in Patients With Acute MI or Unstable Angina.

    Published in:
    JAMA: Journal of the American Medical Association, 2002, v. 288, n. 6, p. 701, doi. 10.1001/jama.288.6.701
    By:
    • Glassman, Alexander H.;
    • O'Connor, Christopher M.;
    • Califf, Robert M.;
    • Swedberg, Karl;
    • Schwartz, Peter;
    • Bigger, Jr, J. Thomas;
    • Krishnan, K. Ranga Rama;
    • van Zyl, Louis T.;
    • Swenson, J. Robert;
    • Finkel, Mitchell S.;
    • Landau, Charles;
    • Shapiro, Peter A.;
    • Pepine, Carl J.;
    • Mardekian, Jack;
    • Harrison, Wilma M.
    Publication type:
    Article
    9

    Kalp Kapak Hastalıkları Tedavi Kılavuzu (2012 versiyonu).

    Published in:
    Archives of the Turkish Society of Cardiology / Türk Kardiyoloji Derneği Arşivi, 2013, v. 41, p. 83
    By:
    • Vahanian, Alec;
    • Alfieri, Ottavio;
    • Andreotti, Felicita;
    • Antunes, Manuel J.;
    • Baro'n-Esquivias, Gonzalo;
    • Baumgartner, Helmut;
    • Borger, Michael Andrew;
    • Carrel, Thierry P.;
    • De Bonis, Michele;
    • Evangelista, Arturo;
    • Falk, Volkmar;
    • Iung, Bernard;
    • Lancellotti, Patrizio;
    • Pierard, Luc;
    • Price, Susanna;
    • Schafers, Hans-Joachim;
    • Schuler, Gerhard;
    • Stepinska, Janina;
    • Swedberg, Karl;
    • Takkenberg, Johanna
    Publication type:
    Article
    10

    Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials.

    Published in:
    European Heart Journal, 2017, v. 38, n. 10, p. 742, doi. 10.1093/eurheartj/ehw509
    By:
    • Abdul-Rahim, Azmil H.;
    • Perez, Ana-Cristina;
    • MacIsaac, Rachael L.;
    • Jhund, Pardeep S.;
    • Claggett, Brian L.;
    • Carson, Peter E.;
    • Komajda, Michel;
    • McKelvie, Robert S.;
    • Zile, Michael R.;
    • Swedberg, Karl;
    • Yusuf, Salim;
    • Pfeffer, Marc A.;
    • Solomon, Scott D.;
    • Lip, Gregory Y. H.;
    • Lees, Kennedy R.;
    • McMurray, John J. V.
    Publication type:
    Article
    11
    12

    2015 ESC Guidelines for the diagnosis and management of pericardial diseases.

    Published in:
    European Heart Journal, 2015, v. 36, n. 42, p. 2921, doi. 10.1093/eurheartj/ehv318
    By:
    • Adler, Yehuda;
    • Charron, Philippe;
    • Imazio, Massimo;
    • Badano, Luigi;
    • Barón-Esquivias, Gonzalo;
    • Bogaert, Jan;
    • Brucato, Antonio;
    • Gueret, Pascal;
    • Klingel, Karin;
    • Lionis, Christos;
    • Maisch, Bernhard;
    • Mayosi, Bongani;
    • Pavie, Alain;
    • Ristic, Arsen D.;
    • Sabate, Manel;
    • Seferovic, Petar;
    • Swedberg, Karl;
    • Tomkowski, Witold
    Publication type:
    Article
    13

    Efficacy and safety of LCZ696 (sacubitrilvalsartan) according to age: insights from PARADIGM-HF.

    Published in:
    European Heart Journal, 2015, v. 36, n. 38, p. 2576, doi. 10.1093/eurheartj/ehv330
    By:
    • Jhund, Pardeep S.;
    • Fu, Michael;
    • Bayram, Edmundo;
    • Chen, Chen-Huan;
    • Negrusz-Kawecka, Marta;
    • Rosenthal, Arvo;
    • Desai, Akshay S.;
    • Lefkowitz, Martin P.;
    • Rizkala, Adel R.;
    • Rouleau, Jean L.;
    • Shi, Victor C.;
    • Solomon, Scott D.;
    • Swedberg, Karl;
    • Zile, Michael R.;
    • McMurray, John J. V.;
    • Packer, Milton
    Publication type:
    Article
    14
    15

    Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients.

    Published in:
    European Heart Journal, 2015, v. 36, n. 30, p. 1990, doi. 10.1093/eurheartj/ehv186
    By:
    • Desai, Akshay S.;
    • McMurray, John J. V.;
    • Packer, Milton;
    • Swedberg, Karl;
    • Rouleau, Jean L.;
    • Fabian Chen;
    • Jianjian Gong;
    • Rizkala, Adel R.;
    • Brahimi, Abdel;
    • Claggett, Brian;
    • Finn, Peter V.;
    • Hartley, Loren Howard;
    • Jiankang Liu;
    • Lefkowitz, Martin;
    • Victor Shi;
    • Zile, Michael R.;
    • Solomon, Scott D.
    Publication type:
    Article
    16

    Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysis.

    Published in:
    European Heart Journal, 2015, v. 36, n. 18, p. 1106, doi. 10.1093/eurheartj/ehu490
    By:
    • Jackson, Colette E.;
    • Castagno, Davide;
    • Maggioni, Aldo P.;
    • Køber, Lars;
    • Squire, Iain B.;
    • Swedberg, Karl;
    • Andersson, Bert;
    • Richards, A. Mark;
    • Bayes-Genis, Antoni;
    • Tribouilloy, Christophe;
    • Dobson, Joanna;
    • Ariti, Cono A.;
    • Poppe, Katrina K.;
    • Earle, Nikki;
    • Whalley, Gillian;
    • Pocock, Stuart J.;
    • Doughty, Robert N.;
    • McMurray, John J. V.
    Publication type:
    Article
    17
    18

    A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure.

    Published in:
    European Heart Journal, 2015, v. 36, n. 7, p. 434
    By:
    • McMurray, John;
    • Packer, Milton;
    • Desai, Akshay;
    • Gong, Jianjian;
    • Greenlaw, Nicola;
    • Lefkowitz, Martin;
    • Rizkala, Adel;
    • Shi, Victor;
    • Rouleau, Jean;
    • Solomon, Scott;
    • Swedberg, Karl;
    • Zile, Michael R.;
    • Andersen, Karl;
    • Arango, Juan Luis;
    • Arnold, Malcolm;
    • Be˘lohlávek, Jan;
    • Böhm, Michael;
    • Boytsov, Sergey;
    • Burgess, Lesley;
    • Cabrera, Walter
    Publication type:
    Article
    19
    20

    Risk stratification for sudden cardiac death: current status and challenges for the future†.

    Published in:
    European Heart Journal, 2014, v. 35, n. 25, p. 1642, doi. 10.1093/eurheartj/ehu176
    By:
    • Wellens, Hein J.J.;
    • Schwartz, Peter J.;
    • Lindemans, Fred W.;
    • Buxton, Alfred E.;
    • Goldberger, Jeffrey J.;
    • Hohnloser, Stefan H.;
    • Huikuri, Heikki V.;
    • Kääb, Stefan;
    • La Rovere, Maria Teresa;
    • Malik, Marek;
    • Myerburg, Robert J.;
    • Simoons, Maarten L.;
    • Swedberg, Karl;
    • Tijssen, Jan;
    • Voors, Adriaan A.;
    • Wilde, Arthur A.
    Publication type:
    Article
    21

    Relaxing from dyspnoea.

    Published in:
    European Heart Journal, 2014, v. 35, n. 16, p. 1017, doi. 10.1093/eurheartj/eht567
    By:
    • Swedberg, Karl
    Publication type:
    Article
    22
    23
    24
    25
    26

    Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial †.

    Published in:
    European Heart Journal, 2013, v. 34, n. 11, p. 835
    By:
    • Ambrosy, Andrew P.;
    • Pang, Peter S.;
    • Khan, Sadiya;
    • Konstam, Marvin A.;
    • Fonarow, Gregg C.;
    • Traver, Brian;
    • Maggioni, Aldo P.;
    • Cook, Thomas;
    • Swedberg, Karl;
    • Burnett, John C.;
    • Grinfeld, Liliana;
    • Udelson, James E.;
    • Zannad, Faiez;
    • Gheorghiade, Mihai
    Publication type:
    Article
    27
    28

    Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice.

    Published in:
    European Heart Journal, 2012, v. 33, n. 22, p. 2782, doi. 10.1093/eurheartj/ehs257
    By:
    • Zannad, Faiez;
    • Gattis Stough, Wendy;
    • Rossignol, Patrick;
    • Bauersachs, Johann;
    • McMurray, John J.V.;
    • Swedberg, Karl;
    • Struthers, Allan D.;
    • Voors, Adriaan A.;
    • Ruilope, Luis M.;
    • Bakris, George L.;
    • O'Connor, Christopher M.;
    • Gheorghiade, Mihai;
    • Mentz, Robert J.;
    • Cohen-Solal, Alain;
    • Maggioni, Aldo P.;
    • Beygui, Farzin;
    • Filippatos, Gerasimos S.;
    • Massy, Ziad A.;
    • Pathak, Atul;
    • Piña, Ileana L.
    Publication type:
    Article
    29

    Guidelines on the management of valvular heart disease (version 2012).

    Published in:
    European Heart Journal, 2012, v. 33, n. 19, p. 2451
    By:
    • Vahanian, Alec;
    • Alfieri, Ottavio;
    • Andreotti, Felicita;
    • Antunes, Manuel J.;
    • Barón-Esquivias, Gonzalo;
    • Baumgartner, Helmut;
    • Borger, Michael Andrew;
    • Carrel, Thierry P.;
    • De Bonis, Michele;
    • Evangelista, Arturo;
    • Falk, Volkmar;
    • Iung, Bernard;
    • Lancellotti, Patrizio;
    • Pierard, Luc;
    • Price, Susanna;
    • Schäfers, Hans-Joachim;
    • Schuler, Gerhard;
    • Stepinska, Janina;
    • Swedberg, Karl;
    • Takkenberg, Johanna
    Publication type:
    Article
    30
    31
    32
    33

    Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial.

    Published in:
    European Heart Journal, 2011, v. 32, n. 20, p. 2563
    By:
    • Blair, John E.A.;
    • Pang, Peter S.;
    • Schrier, Robert W.;
    • Metra, Marco;
    • Traver, Brian;
    • Cook, Thomas;
    • Campia, Umberto;
    • Ambrosy, Andrew;
    • Burnett, John C.;
    • Grinfeld, Liliana;
    • Maggioni, Aldo P.;
    • Swedberg, Karl;
    • Udelson, James E.;
    • Zannad, Faiez;
    • Konstam, Marvin A.;
    • Gheorghiade, Mihai
    Publication type:
    Article
    34
    35
    36
    37

    Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial.

    Published in:
    European Heart Journal, 2010, v. 31, n. 16, p. 1993, doi. 10.1093/eurheartj/ehq190
    By:
    • Scirica, Benjamin M.;
    • Morrow, David A.;
    • Bode, Christoph;
    • Ruzyllo, Witold;
    • Ruda, Mikhail;
    • Oude Ophuis, Anthonius J.M.;
    • Lopez-Sendon, Jose;
    • Swedberg, Karl;
    • Ogorek, Michal;
    • Rifai, Nader;
    • Lukashevich, Valentina;
    • Maboudian, Mojdeh;
    • Cannon, Christopher P.;
    • McCabe, Carolyn H.;
    • Braunwald, Eugene
    Publication type:
    Article
    38

    Corrigendum to: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in ...

    Published in:
    European Heart Journal, 2010, v. 31, n. 5, p. 624, doi. 10.1093/eurheartj/ehq027
    By:
    • Dickstein, Kenneth;
    • Cohen-Solal, Alain;
    • Filippatos, Gerasimos;
    • McMurray, John J.V.;
    • Ponikowski, Piotr;
    • Poole-Wilson, Philip Alexander;
    • Strömberg, Anna;
    • van Veldhuisen, Dirk J.;
    • Atar, Dan;
    • Hoes, Arno W.;
    • Keren, Andre;
    • Mebazaa, Alexandre;
    • Nieminen, Markku;
    • Priori, Silvia Giuliana;
    • Swedberg, Karl
    Publication type:
    Article
    39

    Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials.

    Published in:
    European Heart Journal, 2009, v. 30, n. 24, p. 3015
    By:
    • Metra, Marco;
    • Eichhorn, Eric;
    • Abraham, William T.;
    • Linseman, Jennifer;
    • Böhm, Michael;
    • Corbalan, Ramon;
    • DeMets, David;
    • De Marco, Teresa;
    • Elkayam, Uri;
    • Gerber, Michael;
    • Komajda, Michel;
    • Liu, Peter;
    • Mareev, Vyacheslev;
    • Perrone, Sergio V.;
    • Poole-Wilson, Philip;
    • Roecker, Ellen;
    • Stewart, Jennifer;
    • Swedberg, Karl;
    • Tendera, Michal;
    • Wiens, Brian
    Publication type:
    Article
    40
    41

    Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials.

    Published in:
    Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01545-1
    By:
    • Wijkman, Magnus O.;
    • Claggett, Brian;
    • Vaduganathan, Muthiah;
    • Cunningham, Jonathan W.;
    • Rørth, Rasmus;
    • Jackson, Alice;
    • Packer, Milton;
    • Zile, Michael;
    • Rouleau, Jean;
    • Swedberg, Karl;
    • Lefkowitz, Martin;
    • Shah, Sanjiv J.;
    • Pfeffer, Marc A.;
    • McMurray, John J. V.;
    • Solomon, Scott D.
    Publication type:
    Article
    42
    43

    Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity–mortality trial.

    Published in:
    European Journal of Heart Failure, 2009, v. 11, n. 8, p. 795, doi. 10.1093/eurjhf/hfp098
    By:
    • McMurray, John J. V.;
    • Anand, Inder S.;
    • Diaz, Rafael;
    • Maggioni, Aldo P.;
    • O'Connor, Christopher;
    • Pfeffer, Marc A.;
    • Polu, Krishna R.;
    • Solomon, Scott D.;
    • Yan Sun;
    • Swedberg, Karl;
    • Tendera, Michal;
    • Van Veldhuisen, Dirk J.;
    • Wasserman, Scott M.;
    • Young, James B.
    Publication type:
    Article
    44
    45
    46
    47

    Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).

    Published in:
    2009
    By:
    • Hawkins NM;
    • Huang Z;
    • Pieper KS;
    • Solomon SD;
    • Kober L;
    • Velazquez EJ;
    • Swedberg K;
    • Pfeffer MA;
    • McMurray JJ;
    • Maggioni AP;
    • Valsartan in Acute Myocardial Infarction Trial Investigators;
    • Hawkins, Nathaniel M;
    • Huang, Zhen;
    • Pieper, Karen S;
    • Solomon, Scott D;
    • Kober, Lars;
    • Velazquez, Eric J;
    • Swedberg, Karl;
    • Pfeffer, Marc A;
    • McMurray, John J V
    Publication type:
    journal article
    48

    Reviewers 2008.

    Published in:
    European Journal of Heart Failure, 2009, v. 11, n. 3, p. 225, doi. 10.1093/eurjhf/hfp026
    By:
    • Swedberg, Karl
    Publication type:
    Article
    49

    Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).

    Published in:
    European Journal of Heart Failure, 2009, v. 11, n. 3, p. 292, doi. 10.1093/eurjhf/hfp001
    By:
    • Hawkins, Nathaniel M.;
    • Zhen Huang;
    • Pieper, Karen S.;
    • Solomon, Scott D.;
    • Kober, Lars;
    • Velazquez, Eric J.;
    • Swedberg, Karl;
    • Pfeffer, Marc A.;
    • McMurray, John J. V.;
    • Maggioni, Aldo P.
    Publication type:
    Article
    50